Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CLDXCLDX
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in Celldex Therapeutics, Inc.

GOLDMAN SACHS GROUP INC holds 1.6M shares of CLDX (Celldex Therapeutics, Inc.), worth $60.1M as of 2026-Q2. The position was increased (+63.4% shares). CLDX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$60.1M

Current Shares

1.6M

Total Value Change

+$29.7M

Total Shares Change

+412,890

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+63.4%
$60.1M0.0%$37.21
43
2026-Q1
Decreased
988,416
-7.5%
$31.4M0.0%$28.94
0
2025-Q4
Increased
1.1M
+3.8%
$29M0.0%$26.43
30
2025-Q3
Increased
1M
+41.5%
$26.6M0.0%$26.19
38
2025-Q2
Increased
727,504
+4.5%
$14.8M0.0%$20.29
29
2025-Q1
Decreased
696,007
-42.1%
$12.6M0.0%$19.93
0
2024-Q4
New
1.2M
-
$30.4M0.0%$25.12
40

Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used